Lykan BioScience
Hopkinton
About Lykan BioScience
Lykan Bioscience is an innovative contract development and manufacturing services organization (CDMO) focused on cell-based therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Private Equity (Aug 2022)
- Website: lykanbio.com
- Phone: +1 774 341 4200
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/lykan-bioscience-2062701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.